What's Hot

View all perspectives
      RT @DrPetryna: #abst2109 #ACR22 @RheumNow GO-VIBRANT bio-naïve pts w/active PsA Rx w/IV GLM tend respond slower in all

      Olga Petryna DrPetryna

      2 years 5 months ago
      #abst2109 #ACR22 @RheumNow GO-VIBRANT bio-naïve pts w/active PsA Rx w/IV GLM tend respond slower in all domains if ⬆️ age, HAQ-DI score, and spinal pain; smoking gives w/lower odds of HAQ-DI ≤0.5 at W52. minimal SJC& ⬇️enthesitis achieved significantly faster than TJC, HAQ-DI https://t.co/qqmjEAq3Cd
      RT @Yuz6Yusof: #ACR22 Abstr#L08 Is Evusheld effective in the first 6 mths of therapy in #COVID Omicron era? A cohort stu

      Md Yuzaiful Md Yusof Yuz6Yusof

      2 years 5 months ago
      #ACR22 Abstr#L08 Is Evusheld effective in the first 6 mths of therapy in #COVID Omicron era? A cohort study of 157 RMD patients who were fully vaccinated reported 24 (15%) breakthrough infection; only 2 (1%) required hospitalisation. COVID occurred ~3mths post-therapy @RheumNow https://t.co/VJogB2otbn
      RT @uptoTate: Possible new biomarker in early RA? RA patients with high level of measurable fibrogenesis (PRO-C3 serum l

      Dr. Rachel Tate uptoTate

      2 years 5 months ago
      Possible new biomarker in early RA? RA patients with high level of measurable fibrogenesis (PRO-C3 serum levels) less likely to respond to TCZ, as compared to patients with low level of fibrogenesis. Abs 1986 #ACR22 @RheumNow https://t.co/xnyoV2xbWq https://t.co/Vka8UZsrar
      RT @DrPetryna: @RheumNow #ACR22

      Olga Petryna DrPetryna

      2 years 5 months ago
      @RheumNow #ACR22 https://t.co/dO7xDTApqP
      RT @JulianSegan: Immunosuppressants (eg. MTX, RTX, MMF) can reduce immunogenicity to vaccines. VACIMRA study showing no

      Julian Segan JulianSegan

      2 years 5 months ago
      Immunosuppressants (eg. MTX, RTX, MMF) can reduce immunogenicity to vaccines. VACIMRA study showing no difference in disease activity (beyond 1 month) and damage when MTX initiation was delayed by 1 month for the PCV13 pneumococcal vaccine. @RheumNow ABST1960 #ACR22 https://t.co/SKQ2qx3lJG
      RT @DrCassySims: 💤Our PsA patients are not sleeping well 💤

      Abstract #0387 #ACR22 @RheumNow

      😴 247 patients, s

      Catherine Sims, MD DrCassySims

      2 years 5 months ago
      💤Our PsA patients are not sleeping well 💤 Abstract #0387 #ACR22 @RheumNow 😴 247 patients, sleep quality measured via PSQI 🛌 63% had poor sleep quality 💤 Worse sleep associated with female sex, higher disease activity, fatigue, anxiety/depression https://t.co/Wy20qx2Ah4
      RT @RHEUMarampa: To taper or not to taper?
      In this prospective study by Dr. Cho, #SLE patients in complete remission had

      sheila RHEUMarampa

      2 years 5 months ago
      To taper or not to taper? In this prospective study by Dr. Cho, #SLE patients in complete remission had a longer time to flare upon drug tapering vs. those in LLDAS or clinical remission states. #ACR22 @RheumNow ABST#0996 #ACRBEst @rheumarhyme https://t.co/bSGlkc7Tvk
      RT @uptoTate: #ACR22 Abs 1752 finds rates of incident cancer did not differ between patients treated with anti-TNF and o

      Dr. Rachel Tate uptoTate

      2 years 5 months ago
      #ACR22 Abs 1752 finds rates of incident cancer did not differ between patients treated with anti-TNF and other bDMARDs or tsDMARDs. @RheumNow https://t.co/ycnQzrmAjw https://t.co/CSgDq2Gazg
      RT @uptoTate: Abs 1757 at #ACR22 finds women w/ gout have a higher risk of all-cause mortality, which is primarily drive

      Dr. Rachel Tate uptoTate

      2 years 5 months ago
      Abs 1757 at #ACR22 finds women w/ gout have a higher risk of all-cause mortality, which is primarily driven by higher risk of CVD deaths. @RheumNow https://t.co/kPDL2VYRCN https://t.co/9qARr7T4fI
      RT @uptoTate: Abs L04 reviews novel humanized murine model of PsA disease phenotypes mediated by CD8 T Cells. Perhaps th

      Dr. Rachel Tate uptoTate

      2 years 5 months ago
      Abs L04 reviews novel humanized murine model of PsA disease phenotypes mediated by CD8 T Cells. Perhaps this is a step forward in personalized medicine. #ACR22 @RheumNow https://t.co/fPoElqFLI7 https://t.co/4pxBKoPnym
      RT @RHEUMarampa: Prof Petri presents mortality data of their #lupus cohort
      🔅55 yrs - ave age of death from all causes

      sheila RHEUMarampa

      2 years 5 months ago
      Prof Petri presents mortality data of their #lupus cohort 🔅55 yrs - ave age of death from all causes Top 4 common causes of death: 🔅SLE 🔅CVD 🔅Cancer 🔅Infection African-americans had ⬆️proportions of death from infections & renal causes #ACR22 @RheumNow #ABST2068 https://t.co/B5cAfZiRJp
      RT @RHEUMarampa: Is sustained B cell depletion assoc w/⬇️dse flares in #lupus nephritis?
      In this study by Dr D Zisa,

      sheila RHEUMarampa

      2 years 5 months ago
      Is sustained B cell depletion assoc w/⬇️dse flares in #lupus nephritis? In this study by Dr D Zisa, pts treated w/ BCA & had sustained Bcell depletion = ⬇️dse flares 👉Rapid repletion to BCC>100c/uL was assocd w/ 15.2x risk for flares #ACR22 @RheumNow ABST2065 https://t.co/ivSjm98YvZ
      RT @doctorRBC: Is there a difference between IL-17i and TNFi in preventing radiographic progression in radiographic axSp

      Robert B Chao, MD doctorRBC

      2 years 5 months ago
      Is there a difference between IL-17i and TNFi in preventing radiographic progression in radiographic axSpA? Head to head study secukinumab vs. adalimumab biosimilar shows no sig difference with low radiographic progression. #ACRBest Abs#L15 @RheumNow #ACR22 https://t.co/UiHMtakaPz
      RT @uptoTate: Clinical pearl! Abs 1790 at #ACR22 finds bilateral US assessment of knees, wrists and hips provided the be

      Dr. Rachel Tate uptoTate

      2 years 5 months ago
      Clinical pearl! Abs 1790 at #ACR22 finds bilateral US assessment of knees, wrists and hips provided the best sensitivity and specificity for diagnosing CPPD. @RheumNow https://t.co/3zlrNGCek4 https://t.co/hPK3eMH6iY
      RT @AkhilSoodMD: Are we screening & tx approp. for HBV in #IIM?
      Abstr #1864 found:
      - 78% IIM pts were screened for H

      Akhil Sood MD AkhilSoodMD

      2 years 5 months ago
      Are we screening & tx approp. for HBV in #IIM? Abstr #1864 found: - 78% IIM pts were screened for HBV (mean time 21 months from time of dx) - 73% Hep B Core Ab+ on RTX received Ppx tx - IIM pts Hep B Core Ab+ ↑ % +myositis spec ab and reach remission w/ IVIG @RheumNow #ACR22 https://t.co/QlQxGlkIhh

      Podcasts

      • EMR Messaging Woes (4.11.2025)
      • An Epidural Letdown (4.4.2025)
      • Biomarkers in RA

      Catch up on Conference Podcasts

      Key Conference Topics

      Additional Topics

      Filter by Type

      ×